General Diagnostics Pvt. Ltd.

2nd Floor RPT House Plot No. 6, Sec-

24 Turbhe, Navi Mumbai -400705,
Phone No: 022-4045-0000

29 Year(s) 0 Months(s) 0
Name: MRS.SHIMPI KUMARI Age/Gender:
0000001021669

Day(s)/Female

Referred By: DR.PRIYANKA Client Name: N.A

Collection Date: 04-06-2019 11:14:00 Report Release Date: 04-06-2019

Sr.No Investigation Observed Value Reference Range Unit

Complete Haemogram Test

Erythrocytes
1 Total RBC 5.78 4.1-5.1 10^6/µL
2 Hemoglobin 10.4 12.3-15.3 g/dL
3 Hematocrit (PCV) 35 33-57 %
4 Mean Corpuscular Volume (MCV) 60.5 80-96 fL
5 Mean Corpuscular Hemoglobin (MCH) 18 27.5-33.2 pg
6 Mean Corpuscular Hemoglobin Concentration 29.8 29.4- 34.5 g/dL
(MCHC)
7 Red Cell Distribution Width (RDW-CV) 17.4 12-15 %
8 Red Cell Distribution Width-SD(RDW-SD) 36.8 32-60.4 %
9 Nucleated Red Blood Cells 0 0 - 1.36 cells/µL
10 Nucleated Red Blood Cells Percentage 0 0-4 %

Platelets
11 Platelet Count 150 150-450 10³/µL
12 Mean Platelet Volume (MPV) 10.9 6 - 12 fL
13 Platelet Distribution Width (PDW) 14 15.5-18.3 %
14 Plateletcrit (PCT) 0.051 0.12-0.37 %

Leucocytes
15 Total Leucocytes Count 11.2 4.4-11 10^9/L
16 Neutrophils 56 40-77 %
17 Lymphocyte Percentage 33.6 16-44 %
18 Monocytes Percentage 8.9 4-10 %
19 Eosinophils Percentage 1.5 0-7 %
20 Basophils Percentage 0 0-1 %
21 Neutrophils-Absolute Count 6.27 1.8-7.8 10^9/L
22 Lymphocytes-Absolute Count 3.76 1-4.8 10^9/L
23 Monocytes-Absolute Count 1.00 0.2-1.0 10^9/L
24 Eosinophils-Absolute Count 0.17 0-0.45 10^9/L
25 Basophils-Absolute Count 0.00 0-0.2 10^9/L

* The analyte is not in the lab scope.

CRM No :1021669
Sample Received Time: 04-06-2019 11:15:24 Authorized Signatory Authorized Signatory
Report Release Date: 04-06-2019 Dr. Shilpy Singh Dr. Mahesh Hampe
Patient Name: MRS.SHIMPI KUMARI MD (Pathology) MD (Biochemistry) Page 1 of 4
Patient ID: 1021669
 General Diagnostics Pvt. Ltd.
2nd Floor RPT House Plot No. 6, Sec-
24 Turbhe, Navi Mumbai -400705,
Phone No: 022-4045-0000

29 Year(s) 0 Months(s) 0
Name: MRS.SHIMPI KUMARI Age/Gender:
0000001021669

Day(s)/Female

Referred By: DR.PRIYANKA Client Name: N.A

Collection Date: 04-06-2019 11:14:00 Report Release Date: 04-06-2019

Sr.No Investigation Observed Value Reference Range Unit

Pheripheral Blood Smear

26 RBC Morphology Anisocytosis ,

Microcytic,Hypoc
hromic RBCs seen
27 WBC Morphology Leucocytosis
28 Platelets Adequate On
Smear

* The analyte is not in the lab scope.

CRM No :1021669
Sample Received Time: 04-06-2019 11:15:24 Authorized Signatory Authorized Signatory
Report Release Date: 04-06-2019 Dr. Shilpy Singh Dr. Mahesh Hampe
Patient Name: MRS.SHIMPI KUMARI MD (Pathology) MD (Biochemistry) Page 2 of 4
Patient ID: 1021669
 General Diagnostics Pvt. Ltd.
2nd Floor RPT House Plot No. 6, Sec-
24 Turbhe, Navi Mumbai -400705,
Phone No: 022-4045-0000

29 Year(s) 0 Months(s) 0
Name: MRS.SHIMPI KUMARI Age/Gender:
0000001021669

Day(s)/Female

Referred By: DR.PRIYANKA Client Name: N.A

Collection Date: 04-06-2019 11:14:00 Report Release Date: 04-06-2019

Sr.No Investigation Observed Value Reference Range Unit

1 TSH (Thyroid Stimulating Hormone) 4.241 0.35 - 5.5 µIU/ml

Serum, Method: CLIA

Age Group Reference range (µIU/ml)

0 - 7 Days 2.1 - 20.0

8 Days - 1 Month 1.1 - 17.1
2 Month - 5 Years 0.4 - 8.6
6 Years - 18 Years 0.36 - 5.9
19 Years above 0.35 - 5.5
First trimester 0.1 - 2.5
Second trimester 0.2 - 3.0
Third trimester 0.3 - 3.5

Interpretation
1. Conditions associated with increases in TSH include congenital hypothyroidism, primary hypothyroidism, TSH-secreting
pituitary tumors (uncommon), Pituitary resistance to thyroid hormone (uncommon), drugs like dopamine.
2. TSH levels may be seen low in Hyperthyroidism, Pituitary (secondary) hypothyroidism (rare), Nonthyroid illness, drugs.

* The analyte is not in the lab scope.

CRM No :1021669
Sample Received Time: 04-06-2019 11:15:24 Authorized Signatory Authorized Signatory
Report Release Date: 04-06-2019 Dr. Shilpy Singh Dr. Mahesh Hampe
Patient Name: MRS.SHIMPI KUMARI MD (Pathology) MD (Biochemistry) Page 3 of 4
Patient ID: 1021669
 General Diagnostics Pvt. Ltd.
2nd Floor RPT House Plot No. 6, Sec-
24 Turbhe, Navi Mumbai -400705,
Phone No: 022-4045-0000

29 Year(s) 0 Months(s) 0
Name: MRS.SHIMPI KUMARI Age/Gender:
0000001021669

Day(s)/Female

Referred By: DR.PRIYANKA Client Name: N.A

Collection Date: 04-06-2019 11:14:00 Report Release Date: 04-06-2019

Sr.No Investigation Observed Value Reference Range Unit

1 CA125 3.8 < 35 U/mL U/mL

Serum, Method: CLIA

Interpretation
Cancer Antigen 125 (CA-125) is a protein that is present on the surface of most, but not all, ovarian cancer cells. If CA-125
levels fall during therapy, this generally indicates that the cancer is responding to treatment. If CA-125 levels rise or stay the
same, then the cancer may not be responding to therapy. High CA-125 levels after treatment may indicate relapse.

2 Prolactin 21.5 Nonpregnant: 2.8–29.2 ng/mL

Serum, Method: CLIA Postmenopausal: 1.8–20.3
Pregnant: 9.7–208.5

Interpretation
Prolactin is a hormone produced by the anterior portion of the pituitary gland. Prolactin testing may be used, along with other
hormone tests, to help to determine the cause of breast milk production not associated with pregnancy or breast-feeding
(galactorrhea), diagnose the cause of infertility and erectile dysfunction in men, diagnose the cause of menstrual irregularities
and/or infertility in women, to detect and diagnose tumors that produce excess prolactin (prolactinomas), monitor their
treatment, and detect recurrences, to evaluate anterior pituitary function or other pituitary disorder.

End Of Report

* The analyte is not in the lab scope.

CRM No :1021669
Sample Received Time: 04-06-2019 11:15:24 Authorized Signatory Authorized Signatory
Report Release Date: 04-06-2019 Dr. Shilpy Singh Dr. Mahesh Hampe
Patient Name: MRS.SHIMPI KUMARI MD (Pathology) MD (Biochemistry) Page 4 of 4
Patient ID: 1021669